These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 20133863)
1. Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130. Hegan DC; Lu Y; Stachelek GC; Crosby ME; Bindra RS; Glazer PM Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2201-6. PubMed ID: 20133863 [TBL] [Abstract][Full Text] [Related]
2. Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia. Bindra RS; Glazer PM Oncogene; 2007 Mar; 26(14):2048-57. PubMed ID: 17001309 [TBL] [Abstract][Full Text] [Related]
3. Cediranib suppresses homology-directed DNA repair through down-regulation of BRCA1/2 and RAD51. Kaplan AR; Gueble SE; Liu Y; Oeck S; Kim H; Yun Z; Glazer PM Sci Transl Med; 2019 May; 11(492):. PubMed ID: 31092693 [TBL] [Abstract][Full Text] [Related]
4. NELF complex fosters BRCA1 and RAD51 recruitment to DNA damage sites and modulates sensitivity to PARP inhibition. Bishara LA; Machour FE; Awwad SW; Ayoub N DNA Repair (Amst); 2021 Jan; 97():103025. PubMed ID: 33248388 [TBL] [Abstract][Full Text] [Related]
5. Sensitivity to poly(ADP-ribose) polymerase (PARP) inhibition identifies ubiquitin-specific peptidase 11 (USP11) as a regulator of DNA double-strand break repair. Wiltshire TD; Lovejoy CA; Wang T; Xia F; O'Connor MJ; Cortez D J Biol Chem; 2010 May; 285(19):14565-71. PubMed ID: 20233726 [TBL] [Abstract][Full Text] [Related]
6. Acquired resistance to combination treatment with temozolomide and ABT-888 is mediated by both base excision repair and homologous recombination DNA repair pathways. Liu X; Han EK; Anderson M; Shi Y; Semizarov D; Wang G; McGonigal T; Roberts L; Lasko L; Palma J; Zhu GD; Penning T; Rosenberg S; Giranda VL; Luo Y; Leverson J; Johnson EF; Shoemaker AR Mol Cancer Res; 2009 Oct; 7(10):1686-92. PubMed ID: 19825992 [TBL] [Abstract][Full Text] [Related]
7. Involvement of homologous recombination in the synergism between cisplatin and poly (ADP-ribose) polymerase inhibition. Sakogawa K; Aoki Y; Misumi K; Hamai Y; Emi M; Hihara J; Shi L; Kono K; Horikoshi Y; Sun J; Ikura T; Okada M; Tashiro S Cancer Sci; 2013 Dec; 104(12):1593-9. PubMed ID: 24033642 [TBL] [Abstract][Full Text] [Related]
8. The use of Olaparib (AZD2281) potentiates SN-38 cytotoxicity in colon cancer cells by indirect inhibition of Rad51-mediated repair of DNA double-strand breaks. Tahara M; Inoue T; Sato F; Miyakura Y; Horie H; Yasuda Y; Fujii H; Kotake K; Sugano K Mol Cancer Ther; 2014 May; 13(5):1170-80. PubMed ID: 24577941 [TBL] [Abstract][Full Text] [Related]
9. PARP inhibition versus PARP-1 silencing: different outcomes in terms of single-strand break repair and radiation susceptibility. Godon C; Cordelières FP; Biard D; Giocanti N; Mégnin-Chanet F; Hall J; Favaudon V Nucleic Acids Res; 2008 Aug; 36(13):4454-64. PubMed ID: 18603595 [TBL] [Abstract][Full Text] [Related]
10. [From poly(ADP-ribose) discovery to PARP inhibitors in cancer therapy]. Schreiber V; Illuzzi G; Héberlé E; Dantzer F Bull Cancer; 2015 Oct; 102(10):863-73. PubMed ID: 26384693 [TBL] [Abstract][Full Text] [Related]
11. [PARP inhibitors--theoretical basis and clinical application]. Dębska S; Kubicka J; Czyżykowski R; Habib M; Potemski P Postepy Hig Med Dosw (Online); 2012 May; 66():311-21. PubMed ID: 22706117 [TBL] [Abstract][Full Text] [Related]
12. Chromodomain helicase DNA-binding protein 4 (CHD4) regulates homologous recombination DNA repair, and its deficiency sensitizes cells to poly(ADP-ribose) polymerase (PARP) inhibitor treatment. Pan MR; Hsieh HJ; Dai H; Hung WC; Li K; Peng G; Lin SY J Biol Chem; 2012 Feb; 287(9):6764-72. PubMed ID: 22219182 [TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribose) polymerase-1 protects excessive DNA strand breaks from deterioration during repair in human cell extracts. Parsons JL; Dianova II; Allinson SL; Dianov GL FEBS J; 2005 Apr; 272(8):2012-21. PubMed ID: 15819892 [TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-ribose) contributes to an association between poly(ADP-ribose) polymerase-1 and xeroderma pigmentosum complementation group A in nucleotide excision repair. King BS; Cooper KL; Liu KJ; Hudson LG J Biol Chem; 2012 Nov; 287(47):39824-33. PubMed ID: 23038248 [TBL] [Abstract][Full Text] [Related]
18. Sensitization to radiation and alkylating agents by inhibitors of poly(ADP-ribose) polymerase is enhanced in cells deficient in DNA double-strand break repair. Löser DA; Shibata A; Shibata AK; Woodbine LJ; Jeggo PA; Chalmers AJ Mol Cancer Ther; 2010 Jun; 9(6):1775-87. PubMed ID: 20530711 [TBL] [Abstract][Full Text] [Related]
19. Ganetespib overcomes resistance to PARP inhibitors in breast cancer by targeting core proteins in the DNA repair machinery. Jiang J; Lu Y; Li Z; Li L; Niu D; Xu W; Liu J; Fu L; Zhou Z; Gu Y; Xia F Invest New Drugs; 2017 Jun; 35(3):251-259. PubMed ID: 28111726 [TBL] [Abstract][Full Text] [Related]
20. 4-Amino-1,8-naphthalimide: a novel inhibitor of poly(ADP-ribose) polymerase and radiation sensitizer. Schlicker A; Peschke P; Bürkle A; Hahn EW; Kim JH Int J Radiat Biol; 1999 Jan; 75(1):91-100. PubMed ID: 9972795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]